Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Revolution Medicines
RVMD
$44B
| $20M | 0.01% |
428,309
-952,532
| -69% | -$37.3M |
|
1602
RH
RH
$3.71B
| $20M | 0.01% |
98,349
+47,893
| +95% | +$10.4M |
|
|
SGI
1603
Somnigroup International
SGI
$13.7B
| $20M | 0.01% |
236,726
-222,792
| -48% | -$17.6M |
|
1604
Westamerica Bancorp
WABC
$1.37B
| $20M | 0.01% |
399,197
+200,884
| +101% | +$9.95M |
|
1605
Banco Bradesco
BBD
$36.7B
| $20M | 0.01% |
5,903,734
+1,162,681
| +25% | +$3.51M |
|
|
1606
Thomson Reuters
TRI
$44.1B
| $19.9M | 0.01% |
126,190
-2,371,514
| -95% | -$442M |
|
1607
iShares MSCI India ETF
INDA
$6.63B
| $19.9M | 0.01% |
382,159
+3,818
| +1% | +$204K |
|
|
DMIIU
1608
Drugs Made In America Acquisition II Corp Unit
DMIIU
| $19.9M | 0.01% |
+2,000,000
| New | +$19.9M |
|
1609
PUT
Union Pacific
UNP
$174B
| $19.8M | 0.01% |
83,900
-122,500
| -59% | -$27.6M |
|
|
CON
1610
Concentra Group Holdings
CON
$4.36B
| $19.8M | 0.01% |
945,958
+143,180
| +18% | +$3.05M |
|
1611
Sharplink Inc
SBET
$1.35B
| $19.8M | 0.01% |
1,163,593
+1,149,656
| +8,249% | +$22.6M |
|
1612
Grindr
GRND
$2.95B
| $19.8M | 0.01% |
1,316,704
-3,380
| -0.3% | -$59.3K |
|
1613
Jabil
JBL
$35.8B
| $19.8M | 0.01% |
90,959
-335,013
| -79% | -$73M |
|
1614
RxSight
RXST
$260M
| $19.7M | 0.01% |
2,193,062
+1,241,885
| +131% | +$10.9M |
|
1615
CALL
UBS Group
UBS
$176B
| $19.7M | 0.01% |
550,200
-131,800
| -19% | -$5.12M |
|
1616
Molina Healthcare
MOH
$10.3B
| $19.7M | 0.01% |
102,812
+74,650
| +265% | +$13.7M |
|
1617
CALL
Old Dominion Freight Line
ODFL
$44.9B
| $19.7M | 0.01% |
139,600
+63,000
| +82% | +$9.64M |
|
1618
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $19.6M | 0.01% |
50,100
+10,200
| +26% | +$4.26M |
|
1619
PUT
Rithm Capital
RITM
$5.69B
| $19.6M | 0.01% |
1,720,200
-249,900
| -13% | -$3.03M |
|
1620
CALL
Ares Management
ARES
$30.9B
| $19.6M | 0.01% |
122,400
+94,200
| +334% | +$17M |
|
1621
Oshkosh
OSK
$9.59B
| $19.6M | 0.01% |
150,824
+142,452
| +1,702% | +$18.9M |
|
1622
Avnet
AVT
$7.92B
| $19.5M | 0.01% |
373,422
+173,579
| +87% | +$9.34M |
|
1623
DXC Technology
DXC
$1.73B
| $19.5M | 0.01% |
1,429,857
-270,111
| -16% | -$3.84M |
|
1624
CALL
Arm
ARM
$302B
| $19.5M | 0.01% |
137,600
+26,200
| +24% | +$3.82M |
|
1625
CALL
BILL Holdings
BILL
$4.78B
| $19.5M | 0.01% |
367,200
+302,800
| +470% | +$14.1M |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.